Investors

 

We take seriously the trust our shareholders place in us to deliver on our mission. Explore our earnings reports, investor events and stock information to learn more about our commitment to global healthcare.

Last Updated:

Minimum 15 minutes delayed. Source:

News

Oct. 29, 2024
Viatris Named to Forbes' World's Top Companies for Women 2024 List
Learn more
Oct. 29, 2024
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
Learn more
Oct. 16, 2024
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
Learn more
Explore press releases

Events & presentations

November 21, 2024
at 5:30 AM EST
November 12, 2024
at 11:45 AM EST
Browse all events
Show all

Second Quarter 2024 Financial Results

Featured Documents

Our Leaders

Our leaders

 
Our seasoned executive management team and board of directors bring decades of expertise, knowledge and strategic vision to Viatris.
Meet our leaders

Corporate governance

 
Viatris is a publicly traded company that is managed and controlled under the oversight of the company’s board of directors. Learn more about the guidelines, committee charters and other documents that describe our corporate governance framework.
Learn more

Corporate responsibility

 
As we work to help patients live healthier at every stage of life, we continue to advance responsible and sustainable operations, recognizing that our actions affect the stakeholders and communities we serve.
Learn more

FAQs

 
Browse our list of questions frequently asked by investors or reach out to our team for more information about Viatris.
Investor-related FAQs

Email Alerts

Contact Us

LinkedIn